LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock

LifeMD Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications including urgent and primary care men's and women's health and dermatology chronic care management and others in the United States. The company provides ShapiroMD a telehealth platform brand that offers access to virtual medical treatment prescription medications patented doctor formulated OTC products topical compounded medications and food and drug administration approved medical device for male and female hair loss; RexMD a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care a virtual primary care platform that provides patients with primary care urgent care and chronic care needs as well as offers a mobile first platform that incorporates virtual consultations and treatment prescription medications diagnostics and imaging; Cleared a telehealth brand that provides personalized treatments for allergy asthma and immunology; and NavaMD a female-oriented and tele-dermatology brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli an online software-as-a-service platform that allows users to create edit convert sign and share PDF documents. The company sells its products directly to consumers and through e-commerce platforms as well as through third party partner channels. The company was formerly known as Conversion Labs Inc. and changed its name to LifeMD Inc. in February 2021. LifeMD Inc. was founded in 1994 and is headquartered in New York New York.